Treatment of Advanced Pancreatic Cancer with Combination of Gemcitabine and Oxaliplatin
Hong Lian
Abstract
Hong Lian
Abstract
Objective To evaluate the efficacy and safety of gemcitabine and oxaliplatin in the patients with advanced pancreatic cancer.Methods Twenty-one patients were enrolled.The treatment consisted of gemcitabine 1000 mg/m~2(30 minute infusion)on day 1 and 8 and oxaliplatin 130 mg/m~2(2 hour infusion)on day 1 every 3~4 weeks.Results Sixteen patients were evaluable.Complete response was observed in 0 patient.Partial responses were observed in 2 patients,stable disease in 8 and progress disease in 6.The overall response was 12.5%.The Treatment was well tolerated.Conclusion Gemcitabine and oxaliplatin showed encouraging activity in the patients with advanced pancreatic cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the efficacy and safety of gemcitabine and oxaliplatin in the patients with advanced pancreatic cancer.Methods Twenty-one patients were enrolled.The treatment consisted of gemcitabine 1000 mg/m~2(30 minute infusion)on day 1 and 8 and oxaliplatin 130 mg/m~2(2 hour infusion)on day 1 every 3~4 weeks.Results Sixteen patients were evaluable.Complete response was observed in 0 patient.Partial responses were observed in 2 patients,stable disease in 8 and progress disease in 6.The overall response was 12.5%.The Treatment was well tolerated.Conclusion Gemcitabine and oxaliplatin showed encouraging activity in the patients with advanced pancreatic cancer.
Key concepts: Gemcitabine, Oxaliplatin, Medicine, Pancreatic cancer, Internal medicine, Oncology, Progressive disease, Chemotherapy